Stay updated on Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with California sites; removed California Locations and the HHS Vulnerability Disclosure link, and updated the page to revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:39:09.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.2 replacing v3.2.0; no study details, eligibility criteria, or results are altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:21:45.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed the global government-funding notice about possible delays and operating status. There are no changes to the study details, eligibility criteria, or trial outcomes on the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:49:34.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The two screenshots show only superficial UI changes to the study page; core study information (title, conditions, eligibility, interventions, outcomes) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:39:14.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Core content updated to reflect a new operating-status notice and a new version (v3.2.0); previous version v3.1.0 removed.
    Difference
    5%
    Check dated 2025-10-06T04:55:53.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.
    Difference
    0.1%
    Check dated 2025-09-29T02:55:55.000Z thumbnail image

Stay in the know with updates to Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib + T-DM1 in HER2+ Breast Cancer Clinical Trial page.